James A. Oo

James A. Oo

Auto-generated profile, based on publicly available information

James A. Oo

Goethe University, Institute for Cardiovascular Physiology, Frankfurt, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Circulation Research
Verified
Journal Article
Closed access
JHJiong Hu
Jiong Hu
Matthias S. LeisegangMatthias S. Leisegang
Matthias S. Leisegang
MLMario Looso
Mario Looso
MDMaria-Kyriaki Drekolia
Maria-Kyriaki Drekolia
JWJanina Wittig
Janina Wittig
SBSofia-Iris Bibli
Sofia-Iris Bibli
BACKGROUND: Advanced age is unequivocally linked to the development of cardiovascular disease; however, the mechanisms resulting in reduced endothelial cell regeneration remain poorly understood. Here, we investigated novel mechanisms involved in endothelial cell senescence that impact endothelial cell transcription and vascular repair after injury. METHODS: Native endothelial cells were isolated from young (20±3.4 years) and aged (80±2.3 years) individuals and subjected to molecular analyses to assess global transcriptional and metabolic changes. In vitro studies were conducted using primary human and murine endothelial cells. A murine aortic re-endothelialization model was used to examine endothelial cell regenerative capacity in vivo. RESULTS: RNA sequencing of native endothelial cells revealed that aging resulted in p53-mediated reprogramming to express senescence-associated genes and suppress glycolysis. Reduced glucose uptake and ATP contributed to attenuated assembly of the telomerase complex, which was required for endothelial cell proliferation. Enhanced p53 activity in aging was linked to its acetylation on K120 due to enhanced activity of the acetyltransferase MOZ (monocytic leukemic zinc finger). Mechanistically, p53 acetylation and translocation were, at least partially, attributed to the loss of the vasoprotective enzyme, CSE (cystathionine γ-lyase). CSE physically anchored p53 in the cytosol to prevent its nuclear translocation and CSE absence inhibited AKT (Protein kinase B)-mediated MOZ phosphorylation, which in turn increased MOZ activity and subsequently p53 acetylation. In mice, the endothelial cell–specific deletion of CSE activated p53, induced premature endothelial senescence, and arrested vascular repair after injury. In contrast, the adeno-associated virus 9–mediated re-expression of an active CSE mutant retained p53 in the cytosol, maintained endothelial glucose metabolism and proliferation, and prevented endothelial cell senescence. Adenoviral overexpression of CSE in native endothelial cells from aged individuals maintained low p53 activity and reactivated telomerase to revert endothelial cell senescence. CONCLUSIONS: Aging-associated impairment of vascular repair is partly determined by the vasoprotective enzyme CSE.

15 November 2022 in Cell Reports
Verified
Journal Article
Open access
JOJames A. Oo
James A. Oo
KPKatalin Pálfi
Katalin Pálfi
TWTimothy Warwick
Timothy Warwick
IWIlka Wittig
Ilka Wittig
CPCristian Prieto-Garcia
Cristian Prieto-Garcia
MBmed. P Brandes
med. P Brandes
In healthy vessels, endothelial cells maintain a stable, differentiated, and growth-arrested phenotype for years. Upon injury, a rapid phenotypic switch facilitates proliferation to restore tissue perfusion. Here we report the identification of the endothelial cell-enriched long non-coding RNA (lncRNA) PCAT19, which contributes to the proliferative switch and acts as a safeguard for the endothelial genome. PCAT19 is enriched in confluent, quiescent endothelial cells and binds to the full replication protein A (RPA) complex in a DNA damage- and cell-cycle-related manner. Our results suggest that PCAT19 limits the phosphorylation of RPA2, primarily on the serine 33 (S33) residue, and thereby facilitates an appropriate DNA damage response while slowing cell cycle progression. Reduction in PCAT19 levels in response to either loss of cell contacts or knockdown promotes endothelial proliferation and angiogenesis. Collectively, PCAT19 acts as a dynamic guardian of the endothelial genome and facilitates rapid switching from quiescence to proliferation.

5 April 2019 in Cardiovascular Research
Verified
Journal Article
Closed access
CSChristoph Schürmann
Christoph Schürmann
FDFranziska L Dienst
Franziska L Dienst
KPKatalin Pálfi
Katalin Pálfi
AVAndrea E Vasconez
Andrea E Vasconez
JOJames A Oo
James A Oo
MBmed. P Brandes
med. P Brandes
Aims: The protein Scrib (Scribble 1) is known to control apico-basal polarity in epithelial cells. The role of polarity proteins in the vascular system remains poorly characterized; however, we previously reported that Scrib maintains the endothelial phenotype and directed migration. On this basis, we hypothesized that Scrib has anti-atherosclerotic functions. Methods and results: Tamoxifen-induced Scrib-knockout mice were crossed with ApoE−/− knockout mice and spontaneous atherosclerosis under high-fat diet (HFD), as well as accelerated atherosclerosis in response to partial carotid artery ligation and HFD, was induced. Deletion of Scrib resulted in increased atherosclerosis development in both models. Mechanistically, flow- as well as acetylcholine-induced endothelium-dependent relaxation and AKT phosphorylation was reduced by deletion of Scrib, whereas vascular permeability and leucocyte extravasation were increased after Scrib knockout. Scrib immune pull down in primary carotid endothelial cells and mass spectrometry identified Arhgef7 (Rho Guanine Nucleotide Exchange Factor 7, βPix) as interaction partner. Scrib or Arhgef7 down-regulation by siRNA reduced the endothelial barrier function in human umbilical vein endothelial cells. Gene expression analysis from murine samples and from human biobank material of carotid endarterectomies indicated that loss of Scrib resulted in endothelial dedifferentiation with a decreased expression of endothelial signature genes. Conclusions: By maintaining a quiescent endothelial phenotype, the polarity protein Scrib elicits anti-atherosclerotic functions.

11 April 2025 in Circulation Research
Verified
Journal Article
Closed access
JOJames A. Oo
James A. Oo
TWTimothy Warwick
Timothy Warwick
Matthias S. LeisegangMatthias S. Leisegang
Matthias S. Leisegang

10 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
FBFrederike Boos
Frederike Boos
JOJames A. Oo
James A. Oo
TWTimothy Warwick
Timothy Warwick
SGStefan Günther
Stefan Günther
JPJudit Izquierdo Ponce
Judit Izquierdo Ponce
Matthias S. LeisegangMatthias S. Leisegang
Matthias S. Leisegang
Long non-coding RNAs (lncRNAs) can act as regulatory RNAs which, by altering the expression of target genes, impact on the cellular phenotype and cardiovascular disease development. Endothelial lncRNAs and their vascular functions are largely undefined. Deep RNA-Seq and FANTOM5 CAGE analysis revealed the lncRNA LINC00607 to be highly enriched in human endothelial cells. LINC00607 was induced in response to hypoxia, arteriosclerosis regression in non-human primates and also in response to propranolol used to induce regression of human arteriovenous malformations. siRNA knockdown or CRISPR/Cas9 knockout of LINC00607 attenuated VEGF-A-induced angiogenic sprouting. LINC00607 knockout in endothelial cells also integrated less into newly formed vascular networks in an in vivo assay in SCID mice. Overexpression of LINC00607 in CRISPR knockout cells restored normal endothelial function. RNA- and ATAC-Seq after LINC00607 knockout revealed changes in the transcription of endothelial gene sets linked to the endothelial phenotype and in chromatin accessibility around ERG-binding sites. Mechanistically, LINC00607 interacted with the SWI/SNF chromatin remodeling protein BRG1. CRISPR/Cas9-mediated knockout of BRG1 in HUVEC followed by CUT&RUN revealed that BRG1 is required to secure a stable chromatin state, mainly on ERG-binding sites. In conclusion, LINC00607 is an endothelial-enriched lncRNA that maintains ERG target gene transcription by interacting with the chromatin remodeler BRG1.

8 June 2026 in Nucleic Acids Research
Verified
Journal Article
Open access
SZSimonida Zehr
Simonida Zehr
SSSandra Seredinski
Sandra Seredinski
KPKatalin Pálfi
Katalin Pálfi
JOJames A Oo
James A Oo
EWEmma C Walsh
Emma C Walsh
TWTimothy Warwick
Timothy Warwick
Chromatin-localized RNAs play diverse roles in gene regulation and nuclear architecture. Mapping genome-wide RNA–DNA interactions is possible using a variety of molecular methods, including using bridging oligonucleotides to ligate RNA and DNA in proximity. While molecular methods have progressed, a robust computational method for calling biologically meaningful RNA–DNA interactions from these data is lacking. Herein, we present RADIAnT, a reads-to-interactions pipeline for analyzing RNA–DNA ligation data. RADIAnT calls interactions against a dataset-specific, unified background, which considers RNA binding site–TSS distance and genomic region bias, and outperforms previously proposed methods in the accurate recall of genome-wide RNA–DNA interactions. Accurate RNA–DNA interaction calling enables the analysis of gene regulatory RNAs in dynamic biological contexts. Here, dynamically chromatin-associated RNAs were identified in the physiologically- and pathologically relevant process of endothelial-to-mesenchymal transition. By depleting candidate chromatin-associated lncRNAs, their gene regulatory behavior at bound target genes important to endothelial phenotype maintenance could be validated. These data demonstrate how effective RNA–DNA interaction calling can help to place RNAs at key points in gene regulatory networks governing cellular behavior.